| Literature DB >> 32942994 |
Adam Ciezarek1,2, Luke Gardner3, Vincent Savolainen4, Barbara Block3.
Abstract
BACKGROUND: The Pacific bluefin tuna (Thunnus orientalis) is a regionally endothermic fish that maintains temperatures in their swimming musculature, eyes, brain and viscera above that of the ambient water. Within their skeletal muscle, a thermal gradient exists, with deep muscles, close to the backbone, operating at elevated temperatures compared to superficial muscles near the skin. Their heart, by contrast, operates at ambient temperature, which in bluefin tunas can range widely. Cardiac function in tunas reduces in cold waters, yet the heart must continue to supply blood for metabolically demanding endothermic tissues. Physiological studies indicate Pacific bluefin tuna have an elevated cardiac capacity and increased cold-tolerance compared to warm-water tuna species, primarily enabled by increased capacity for sarcoplasmic reticulum calcium cycling within the cardiac muscles.Entities:
Keywords: Atrium; Calcium cycling; Endothermy; Muscle; Thermogenesis; Tuna
Mesh:
Substances:
Year: 2020 PMID: 32942994 PMCID: PMC7499911 DOI: 10.1186/s12864-020-07058-z
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Tissue sampling of Pacific bluefin tuna in this study. The 50% slice is indicated by dashed arrows on the tuna, with samples taken from the deep and superficial red and white locations indicated on the skeletal muscle image. The red circle indicates approximate location of the heart. Skeletal muscle and heart images were taken for this study. Pacific bluefin tuna image is adapted from http://opencage.info
Sampling and read mapping statistics for each of the 19 tuna samples
| Individual | Sampling date and method of death | Weight (kg) | Tissue and abbreviation | NCBI BioSample accession number | Raw reads | Trimmed reads | Reads pseudo-mapping |
|---|---|---|---|---|---|---|---|
| P1 | 18th October 2016 (euthanised) | 193 | Atrium (P1_A) | SAMN11160657 | 22,128,885 | 22,126,476 | 93.91% |
| Compact ventricle (P1_CV) | SAMN11160658 | 26,586,751 | 26,581,483 | 95.48% | |||
| Spongy ventricle (P1_SV) | SAMN11160659 | 25,366,331 | 25,363,514 | 94.11% | |||
| Deep red muscle (P1_DR) | SAMN11160660 | 24,797,661 | 24,795,701 | 95.84% | |||
| Deep white muscle (P1_DW) | SAMN11160662 | 24,335,135 | 24,333,431 | 98.23% | |||
| Superficial red muscle (P1_SR) | SAMN11160661 | 21,802,262 | 21,800,414 | 97.52% | |||
| Superficial white muscle (P1_SW) | SAMN11160663 | 24,470,032 | 24,468,269 | 97.86% | |||
| P2 | 26th October 2016 (euthanised) | 221.8 | Atrium (P2_A) | SAMN11160664 | 25,730,407 | 25,727,542 | 94.40% |
| Compact ventricle (P2_CV) | SAMN11160665 | 21,486,810 | 21,484,438 | 95.19% | |||
| Spongy ventricle (P2_SV) | SAMN11160666 | 26,953,930 | 26,951,048 | 95.24% | |||
| Deep red muscle (P2_DR) | SAMN11160667 | 24,118,227 | 24,115,974 | 95.87% | |||
| Deep white muscle (P2_DW) | SAMN11160669 | 24,675,179 | 24,673,221 | 97.89% | |||
| Superficial red muscle (P2_SR) | SAMN11160668 | 25,546,590 | 25,543,903 | 95.76% | |||
| Superficial white muscle (P2_SW) | SAMN11160670 | 20,016,233 | 20,014,904 | 97.64% | |||
| P3 | 27th January 2016 (spinal cord severed) | 12.3 | Atrium (P3_A) | SAMN11160671 | 23,870,338 | 23,867,309 | 90.48% |
| Compact ventricle (P3_CV) | SAMN11160672 | 23,073,063 | 23,070,749 | 93.60% | |||
| Spongy ventricle (P3_SV) | SAMN11160673 | 25,881,447 | 25,878,760 | 92.93% | |||
| Deep white muscle (P3_DW) | SAMN11160674 | 23,560,483 | 23,558,851 | 98.32% | |||
| Superficial white muscle (P3_SW) | SAMN11160675 | 24,966,983 | 24,965,661 | 98.10% |
Fig. 2Heatmap (left hand side) and PCA (right hand side) showing clustering of each of the 19 samples. Panel a shows clustering before outlier (P1_CV and P1_SR) removal. Outliers in the heatmap are highlighted in red text and with *, and are labelled on the PCA. Panel b shows clustering after outlier removal. Annotations under heatmap in panel b demonstrate clustering of samples by tissue. Abbreviations: RM - red muscle; WM - white muscle; SV - spongy ventricle; CV - compact ventricle. See Table 1 for full abbreviations of each sample
Fig. 3Number of differentially expressed genes in each tissue type for the five pairwise comparisons, out of 31,610 total genes
Gene Ontology (GO) terms enriched and KEGG pathways upregulated relating to aerobic or anaerobic metabolism and calcium cycling in each tissue. For full list and p values, see Table S2. None means no GO term was enriched and no KEGG pathways upregulated
| Tissue | Compared against | Metabolic or calcium cycling upregulated GO terms | |
|---|---|---|---|
| Pathway | GO terms and KEGG pathways upregulated for each category | ||
| White muscle | Red muscle | Anaerobic metabolism | Molecular Function: 1 (6-phosphofructokinase activity) |
| Biological Process: 6 (Glycogen metabolic process, Glycolytic process, Fructose 6-phosphate metabolic process, Gluconeogenesis, Carbohydrate metabolic process, Glycolytic process through fructose-6-phosphate) | |||
| KEGG Pathway: 1 (Glycolysis/ gluconeogenesis) | |||
| Calcium cycling | Cellular Component: 1 (Endoplasmic reticulum membrane) | ||
| Biological Process: 2 (Release of sequestered calcium ion into cytosol, Calcium ion homeostasis) | |||
| KEGG Pathway: 1 (Calcium signalling pathway) | |||
| Red muscle | White muscle | Aerobic metabolism | Cellular Component: 3 (Mitochondrial matrix, Proton-transporting ATP synthase complex, coupling factor f(o), Mitochondrial membrane) |
| Molecular Function: 4 (CoA-ligase activity, Cytochrome-c oxidase activity, NAD binding, Isocitrate dehydrogenase activity) | |||
| Biological Process: 9 (Tricarboxylic acid cycle, ATP synthesis coupled proton transport, ATP hydrolysis coupled cation transmembrane transport, Mitochondrial ATP synthesis coupled electron transport, Electron transport chain, Acyl-CoA metabolic process, Acetyl-CoA biosynthetic process, ATP synthesis coupled electron transport, Mitochondrial transport) | |||
| KEGG Pathway: 2 (TCA cycle, Oxidative phosphorylation) | |||
| Calcium cycling | Molecular Function: 1 (Calcium-transporting ATPase activity) | ||
| Deep white muscle | Superficial white muscle | None | None |
| Superficial white muscle | Deep white muscle | Calcium cycling | Molecular Function: 1 (Calcium-release channel activity) |
| Deep red muscle | Superficial red muscle | 0 | None |
| Superficial red muscle | Deep red muscle | Calcium cycling | Molecular Function: 1 (Calcium-release channel activity) |
| KEGG Pathway: 1 (Calcium signalling pathway) | |||
| Atrium | Ventricle | Anaerobic metabolism | Molecular Function: 1 (6-phosphofructokinase activity) |
| Biological Process: 2 (Glycolytic process through fructose-6-phosphate, Fructose 6-phosphate metabolic process) | |||
| Calcium cycling | Molecular Function: 2 (Calcium ion binding, Calcium-transporting ATPase activity) | ||
| Biological Process: 2 (Calcium ion transmembrane transport, Regulation of calcium ion transmembrane transporter activity) | |||
| Ventricle | Atrium | Aerobic metabolism | Cellular Component: 4 (Respiratory chain complex, Inner mitochondrial membrane protein complex, Mitochondrial respiratory chain, Mitochondrial membrane) |
| Molecular Function: 4 (Proton-transporting ATP synthase activity, rotational mechanism, Electron transfer activity, CoA-ligase activity, Acid-thiol ligase activity) | |||
| Biological Process: 2 (Fatty acid beta-oxidation, ATP synthesis coupled proton transport) | |||
| KEGG Pathway: (TCA cycle, oxidative phosphorylation) | |||
| Anaerobic metabolism (3) | Biological Process: 2 (Carbohydrate metabolic process, Glycolytic process) | ||
| KEGG Pathway: 1 (Glycolysis / gluconeogenesis) | |||
| Calcium cycling (1) | Molecular function: 1 (Ryanodine-sensitive calcium-release channel activity) | ||
| Spongy ventricle | Compact ventricle | 0 | None |
| Compact ventricle | Spongy ventricle | 0 | None |
Fig. 4Overall gene expression and number of differentially expressed genes in KEGG pathways relating to metabolism and cardiac muscle contraction. For the skeletal muscle (top row), comparisons for aerobic (TCA-cycle and oxidative phosphorylation) and anaerobic (glycolysis/ gluconeogenesis) metabolism are given. For the cardiac comparisons (bottom row) comparisons for cardiac contraction, calcium cycling, and adregenic signalling in cardiomyocytes for the cardiac comparisons are also given. The five pairwise comparisons are separated by vertical dashed lines, with the three between-muscle comparisons on the top row. Significance in t-tests of overall expression between each pair of tissues is indicated with a * under the bar representing the tissue with elevated expression, with the Benjamini-Hochberg corrected p-value given below. Bars are coloured red and blue, as indicated to represent each of the two tissues in each comparison. Standard errors are not plotted, but all are below 1% overall gene expression. The bracket above each pair of bars signifies which metabolic pathway it corresponds to with the following abbreviations: Gl – glycolysis / gluconeogenesis; OP – oxidative phosphorylation; TCA – TCA/ citrate cycle; CC – cardiac contraction; Ca2+ − calcium signalling; AS – adregenic signalling in cardiomyocytes